1. New progress in epidemiological research |
Page:1—5 |
2. Conducting systematic researches on influencing factors for healthy ageing and promoting scientific implementation of health promotion program for the elderly |
Page:9—12 |
3. Association of sleep with anxiety in the elderly aged 60 years and older in China |
Page:13—19 |
4. Influencing factors for depressive symptoms in the elderly aged 65 years and older in 8 longevity areas in China |
Page:20—24 |
5. Current status of body mass index and related influencing factors in the elderly aged 65 years and older in 8 longevity areas in China |
Page:25—30 |
6. Influence of visual impairment on mortality in the elderly aged 65 years and older in 8 longevity areas in China |
Page:31—35 |
7. Effects of estimated glomerular filtration rate on all-cause mortality in the elderly aged 65 years and older in 8 longevity areas in China |
Page:36—41 |
8. Prediction of 6-year incidence risk of chronic kidney disease in the elderly aged 65 years and older in 8 longevity areas in China |
Page:42—47 |
9. Frequency of bowel movements and risk of Parkinson’s disease: a prospective cohort study in adults in China |
Page:48—54 |
10. Sugar-sweetened beverages consumption in midlife and risk of late-life cognitive impairment in Chinese adults |
Page:55—61 |
11. A comparative study on diagnostic cut points of dyslipidemia in children and adolescents in China |
Page:62—67 |
12. Awareness, treatment and control of hypertension in 640 000 adults in eastern China |
Page:68—73 |
13. Exposure to famine in fetus and infant period and risk for hypertension in adulthood |
Page:74—78 |
14. Status of child health services in less developed areas in Sichuan province, 2014-2018 |
Page:79—84 |
15. Assessment of data quality of intervention in population at high risk for HIV/AIDS in China, 2014-2018 |
Page:85—89 |
16. Epidemiological characteristics of amoebic dysentery in China, 2015-2018 |
Page:90—95 |
17. HIV infection rate in people aged 50 years and older in China: a Meta-analysis |
Page:96—102 |
18. Meta-analysis on effectiveness of live attenuated influenza vaccine against seasonal influenza in children |
Page:103—110 |
19. A sequential conditional mean model for assessing total effects of exposure in longitudinal data |
Page:111—114 |
20. A bibliometric analysis on cohort study of liver cancer in China |
Page:115—119 |
21. A review of combined immunization: current research situation and its promising future |
Page:120—126 |
22. HIV/AIDS related frailty syndrome in the elderly and related research progress |
Page:127—130 |
23. An update on the epidemiological characteristics of novel coronavirus pneumonia(COVID-19) |
Page:139—144 |
24. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China |
Page:145—151 |
25. Recommendation on the modernization of disease control and prevention |
Page:453—460 |
26. Study on assessing early epidemiological parameters of coronavirus disease epidemic in China |
Page:461—465 |
27. Dynamic basic reproduction number based evaluation for current prevention and control of COVID-19 outbreak in China |
Page:466—469 |
28. Fitting and forecasting the trend of COVID-19 by SEIR+ CAQ dynamic model |
Page:470—475 |
29. Estimating the basic reproduction number of COVID-19 in Wuhan, China |
Page:476—479 |
30. Prediction modeling with data fusion and prevention strategy analysis for the COVID-19 outbreak |
Page:480—484 |
31. Investigation and analysis on characteristics of a cluster of COVID-19 associated with exposure in a department store in Tianjin |
Page:489—493 |
32. Epidemiological analysis on a family cluster of COVID-19 |
Page:506—509 |
33. Potential false-positive rate among the 'asymptomatic infected individuals’ in close contacts of COVID-19 patients |
Page:485—488 |
34. Advances on presymptomatic or asymptomatic carrier transmission of COVID-19 |
Page:485—488 |
35. Comparison of two epidemic patterns of COVID-19 and evaluation of prevention and control effectiveness: an analysis based on Guangzhou and Wenzhou |
Page:E035—E035 |
36. Suggestions on reforming and improving the prevention and treatment system for major epidemic diseases in China |
Page:E054—E054 |
37. Challenges to prevent and control the outbreak of Novel Coronavirus Pneumonia (COVID-19) |
Page:E029—E029 |
38. Thoughts of the COVID-19 outbreak phases changed from emergency response to combination of emergency response and regular prevention and control |
Page:E045—E045 |
39. Asymptomatic and pre-symptomatic cases of COVID-19 contribution to spreading the epidemic and need for targeted control strategies |
Page:E036—E036 |
40. Discussion on early warning, prevention and control of emerging infectious diseases from a macroscopic perspective based on big data and effective distance model: enlightenment of COVID-19 epidemic data in China |
Page:E052—E052 |
41. Clinical outcomes of COVID-19 cases and influencing factors in Guangdong province |
Page:E057—E057 |
42. Epidemiological analysis on 1 052 cases of COVID-19 in epidemic clusters |
Page:E027—E027 |
43. The preliminary analysis on the characteristics of the cluster for the Corona Virus Disease |
Page:623—628 |
44. Risk assessment and early warning of imported COVID-19 in 21 cities, Guangdong province |
Page:658—662 |
45. Epidemiological investigation of a family clustering of COVID-19 |
Page:629—633 |
46. Comparison of epidemic characteristics between SARS in2003 and COVID-19 in 2020 in Guangzhou |
Page:634—637 |
47. Epidemiological investigation on a cluster epidemic of COVID-19 in a collective workplace in Tianjin |
Page:649—653 |
48. Epidemiological characteristics of confirmed COVID-19 cases in Tianjin |
Page:638—642 |
49. Advances on the Asymptomatic Infection of COVID-19 |
Page:E043—E043 |
50. COVID-19 Pandemic: global epidemiological trends and China’s subsequent preparedness and responses |
Page:643—648 |
51. Interim guidelines for prevention and control of COVID-19 for oversea returnees. |
Page:1197—1198 |
52. Interim guidelines for prevention and control of COVID-19 for students back to school. |
Page:1195—1196 |
53. Recommendation on the modernization of disease control and prevention. |
Page:453—460 |
54. Guideline for epidemiological investigation of coronavirus disease 2019 (T/BPMA 0003-2020). |
Page:1184—1191 |
55. Guidelines for personal protection against coronavirus disease 2019 for deseases control person (T/BPMA 0002-2020). |
Page:1180—1183 |
56. Technical requirements for preventive disinfection against coronavirus disease 2019 (T/BPMA 0001-2020). |
Page:1175—1179 |
57. Expert consensus on immunoprophylaxis of pneumococcal disease (2020 version). |
Page:1945—1979 |
58. General principles of description for pathogenic microorganism collection (T/CPMA 011-2020). |
Page:1791—1797 |
59. Estimating the basic reproduction number of COVID-19 in Wuhan, China |
Page:476—479 |
60. Urgent research agenda for the novel coronavirus epidemic: transmission and non-pharmaceutical mitigation strategies. |
Page:135—138 |
61. An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19). |
Page:139—144 |
62. Cluster Investigation Technical Guideline for the 2019 Novel Coronavirus Pneumonia (COVID- 19), China (1st Trial Version). |
Page:293—295 |
63. Good health management practice for chronic diseases (T/CHAA 007-2019). |
Page:6—8 |
64. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. |
Page:145—151 |
65. Cluster investigation Technical Guidelines for the 2019 Novel Coronavirus Pneumonia (COVID-19), China (1st Trial Version). |
Page:293—295 |
66. Consideration on the strategies during epidemic stage changing from emergency response to continuous prevention and control. |
Page:297—300 |
67. Technical services specification for vision health management for primary and middle school students (T/CHAA 008-2019). |
Page:152—161 |
68. Rapid investigation plan of clinical courses and key diagnosis and treatment equipment requirements for the patients of the 2019 Novel Coronavirus Pneumonia (COVID-19). |
Page:296—296 |